X @Bloomberg

"Every patient has a different preference, and we need the products to match that."Novo Nordisk CEO Mike Doustdar tells @GuyJohnsonTV the reason behind the firm's takeover bid for obesity startup Metsera https://t.co/hOTbziTe9e https://t.co/AR35Soh0nt ...